A meeting of the Board of Directors of Caplin Point Laboratories Limited will be held on Wednesday, August 12, 2026. The agenda includes:
- Consideration of quarterly unaudited financial results for the quarter ended June 30, 2026 (both standalone and consolidated)
- Recommendation of Final Dividend for FY 2025-26 for shareholder approval
- Convening of the 35th Annual General Meeting of the Company
- Fixation of record date for determining shareholder eligibility for the Final Dividend
This intimation is provided in compliance with Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The trading window for dealing in the Company's securities by Designated Persons and their immediate relatives remains closed from July 01, 2026 until August 14, 2026 (both days inclusive). This closure is in accordance with the Company's Code of Conduct to regulate, monitor and report trading by insiders, read with SEBI (Prohibition of Insider Trading) Regulations, 2015. This trading window closure was previously communicated via letter dated June 27, 2026.